Inventor · disambiguated record
Joseph P. Balint
Also filed as: BALINT JOSEPH · BALINT JOSEPH P · BALINT JR JOSEPH P
24 granted patents·5 pending applications·490 citations·filing 1983–2024
96Inventor score
Top patents by PatentIndex Score
29 records- 0197US11504423B2Methods and compositions for producing an adenovirus vector for use with multiple vaccinationsETUBICS CORP·Filed 2022·Granted Nov 22, 2022·2 cites·18 claims
- 0295US11826417B2Methods and compositions for producing an adenovirus vector for use with multiple vaccinationsETUBICS CORP·Filed 2022·Granted Nov 28, 2023·1 cites·19 claims
- 0395US11529408B2Methods and compositions for producing an adenovirus vector for use with multiple vaccinationsETUBICS CORP·Filed 2022·Granted Dec 20, 2022·1 cites·19 claims
- 0495US11389521B2Methods and compositions for producing an adenovirus vector for use with multiple vaccinationsETUBICS CORP·Filed 2020·Granted Jul 19, 2022·3 cites·18 claims
- 0593US8298549B2Sequential administration of a replication defective adenovirus vector in vaccination protocolsBALINT JOSEPH P·Filed 2010·Granted Oct 30, 2012·21 cites·26 claims
- 0692US12370250B2Methods and compositions for producing an adenovirus vector for use with multiple vaccinationsETUBICS CORP·Filed 2024·Granted Jul 29, 2025·0 cites·19 claims
- 0792US11376316B2Breast cancer vaccines and methods of use thereofETUBICS CORP·Filed 2016·Granted Jul 5, 2022·3 cites·14 claims
- 0892US11369673B2HPV vaccines and methods of use thereofETUBICS CORP·Filed 2016·Granted Jun 28, 2022·3 cites·16 claims
- 0992US4681870AProtein A-silica immunoadsorbent and process for its productionIMRE CORP·Filed 1985·Granted Jul 21, 1987·137 cites·26 claims
- 1091US11104916B2Compositions and methods for alphavirus vaccinationETUBICS CORP·Filed 2017·Granted Aug 31, 2021·6 cites·17 claims
- 1190US11344613B2Sequential administration of a replication defective adenovirus vector in vaccination protocolsETUBICS CORP·Filed 2012·Granted May 31, 2022·3 cites·16 claims
- 1288US2023364218A1Methods and compositions for producing an adenovirus vector for use with multiple vaccinationsETUBICS CORP·Filed 2023·Application pending·0 cites
- 1387US11304998B2Combination immunotherapies comprising IL-15 superagonistsETUBICS CORP·Filed 2021·Granted Apr 19, 2022·1 cites·9 claims
- 1482US5037649AMethod for treatment of HIV-infected patientsIMRE CORP·Filed 1989·Granted Aug 6, 1991·35 cites·41 claims
- 1581US11116827B2Compositions and methods for tumor vaccination and immunotherapy involving HER antigensETUBICS CORP·Filed 2018·Granted Sep 14, 2021·1 cites·14 claims
- 1681US11020467B2Combination immunotherapies comprising IL-15 superagonistsETUBICS CORP·Filed 2018·Granted Jun 1, 2021·1 cites·10 claims
- 1779US10835596B2Compositions and methods for flavivirus vaccinationETUBICS CORP·Filed 2017·Granted Nov 17, 2020·2 cites·16 claims
- 1873US4699783AProducts and methods for treatment of cancerTERMAN DAVID S·Filed 1983·Granted Oct 13, 1987·38 cites·8 claims
- 1971US5075423APurification of protein a by affinity chromatography followed by anion exchangeIMRE CORP·Filed 1990·Granted Dec 24, 1991·25 cites·15 claims
- 2071US4801449AMethod for treatment of Kaposi's sarcomaIMRE CORP·Filed 1986·Granted Jan 31, 1989·23 cites·10 claims
- 2161US5782792AMethod for treatment of rheumatoid arthritisCYPRESS BIOSCIENCE INC·Filed 1994·Granted Jul 21, 1998·95 cites·13 claims
- 2247US4762787AAnti-human IGM immunoadsorbent and process for producing said immunoadsorbentIMRE CORP·Filed 1986·Granted Aug 9, 1988·4 cites·5 claims
- 2346US4863869AAnti-human IGM immunoadsorbent and process for producing said immunoadsorbentIMRE CORORATION·Filed 1988·Granted Sep 5, 1989·12 cites·7 claims
- 2444US5733254AMethod for treating patients suffering from immune thrombocytopenic purpuraCYPRESS BIOSCIENCE INC·Filed 1995·Granted Mar 31, 1998·44 cites·25 claims
- 2544US2019022209A1Methods and compositions for influenza vaccinationETUBICS CORP·Filed 2017·Application pending·0 cites
- 2643US2019125852A1Compositions and methods for tumor vaccination using prostate cancer-associated antigensETUBICS CORP·Filed 2017·Application pending·0 cites
- 2743US2019134195A1Compositions and methods for the treatment of human papillomavirus (hpv)-associated diseasesETUBICS CORP·Filed 2017·Application pending·0 cites
- 2842US2019134174A1Compositions and methods for tumor vaccination and immunotherapy involving her2/neuETUBICS CORP·Filed 2017·Application pending·0 cites
- 2937US4865841AMethods and compositions for transient elimination of humoral immune antibodiesIMRE CORP·Filed 1987·Granted Sep 12, 1989·29 cites·25 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →